Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Autonomic Research
Published in: Clinical Autonomic Research 1/2017

Open Access 01-07-2017 | Case Vignette

Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease

Authors: Brent P. Goodman, Daniel Claassen, Ali Mehdirad

Published in: Clinical Autonomic Research | Special Issue 1/2017

Login to get access

Excerpt

How does supine hypertension influence the management of neurogenic orthostatic hypotension? …
Literature
1.
Fanciulli A, Gobel G, Ndayisaba JP, Granata R, Duerr S, Strano S, Colosimo C, Poewe W, Pontieri FE, Wenning GK (2016) Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res 26:97–105
2.
Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, Biaggioni I, Robertson D (2009) Renal impairment of pure autonomic failure. Hypertension 54:1057–1061CrossRefPubMedPubMedCentral
3.
Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. doi:10.​1007/​s00415-016-8375-x
4.
Umehara T, Matsuno H, Toyoda C, Oka H (2016) Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res 26:15–21CrossRef
5.
Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H (2000) Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355:725–726CrossRefPubMed
Metadata
Title
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Authors
Brent P. Goodman
Daniel Claassen
Ali Mehdirad
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Autonomic Research / Issue Special Issue 1/2017
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-017-0431-9

Other articles of this Special Issue 1/2017

Clinical Autonomic Research 1/2017 Go to the issue

Case Vignette

Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease

Case Vignette

Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy

Editorial

Neurogenic orthostatic hypotension: the very basics

Case Vignette

Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension

Case Vignette

Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease

Case Vignette

Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus